drugset / Trial / NCT04283513
Treatment of Hemorrhagic Fever With Ribavirin
NaSingle-groupOpen-labelTreatment
Summary
Multisite protocol to provide IV Ribavirin treatment to patients with probable or suspected case of Hemorrhagic Fever with Renal Syndrome (HFRS)
Timeline
- Start
- 2022-10-31
- Primary completion
- 2027-04
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ribavirin | Small molecule | 16 mg/kg | Intravenous |